Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Chromatogr B Analyt Technol Biomed Life Sci ; 878(28): 2831-8, 2010 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-20850394

RESUMO

Simple, sensitive and robust liquid chromatography-tandem mass spectrometer (LC-MS/MS) methods were developed and validated for the determination of lipopeptide polymyxins and glycopeptide vancomycin in rat plasma. The effect of trichloroacetic acid (TCA) concentration on sample recoveries (peak area of sample recovered from plasma/peak area of sample from neat solvent solutions) was studied and an optimized concentration of 30% TCA were determined that gives the best sample recovery for the peptides from rat plasma. The effect of the TCA concentration on the chromatographic behavior of peptides was studied on a Phenomenex Jupiter C18 5µ 300Å 50mm×2mm column using a mobile phase with a pH of 2.8. Other than protein precipitation, TCA also acted as ion pairing reagent and was only present in the samples but not in the mobile phases. The data demonstrated that by increasing the TCA concentration, the analyte retention and sensitivity were improved. The absence of TCA in mobile phase helped to reduce the ion source contamination and to achieve good reproducibility. The plasma method was linearly calibrated from 5 to 5000ng/mL for polymyxins with precisions to be of 2.3-10.8%, and accuracies to be 91.7-107.4% for polymyxin B1, B2, E1, E2, respectively. For vancomycin the calibration is from 1 to 5000ng/mL with precisions to be of 7.8-10.3 and accuracies to be 96.2-102.0%. The LLOQs corresponding with a coefficient of variation less than 20% were 7.5, 18.1, 7.3, 5.0 and 1.0ng/mL for polymyxin B1, B2, E1, E2 and vancomycin, respectively.


Assuntos
Cromatografia Líquida/métodos , Polimixinas/sangue , Espectrometria de Massas em Tandem/métodos , Vancomicina/sangue , Animais , Antibacterianos/sangue , Antibacterianos/química , Antibacterianos/farmacocinética , Modelos Lineares , Polimixinas/química , Polimixinas/farmacocinética , Ratos , Ratos Sprague-Dawley , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Ácido Tricloroacético , Vancomicina/química , Vancomicina/farmacocinética
2.
Comp Med ; 57(6): 563-9, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18246868

RESUMO

We developed a mouse model of Staphylococcus aureus infective endocarditis to evaluate the efficacy of experimental antibacterial compounds for this disease. Experimental infective endocarditis was produced in CD1 mice by intravenous challenge with approximately 6 log10 colony-forming units (CFU) of methicillin-sensitive (MSSA) SA-3529 or -resistant (MRSA) SA-2015 S. aureus 1 d after aortic valve trauma. Valve trauma was produced by introduction of an indwelling 32-gauge polyurethane catheter into the aortic valve via the left carotid artery. Histologic examination of MSSA- and MRSA-infected and catheterized aortic valve sections revealed neutrophilic inflammation and vegetative bacterial colonies encapsulated within fibrin along the aortic valves 1 d after infection. The MSSA or MRSA endocarditis was determined to be catheter-dependent based on catheterized mice exhibiting heart bacterial counts 4 orders of magnitude greater than those seen for noncatheterized mice. The model was validated by using a 3-d regimen of vancomycin at exposures comparable to human dosing (500 microg x h/ml). Vancomycin treatment produced statistically significant reductions of 3.4 and 3.1 log10 CFU/heart for MSSA and MRSA, respectively, relative to controls. This mouse model of endocarditis shows promise in evaluating the predictive efficacy of antibiotics for S. aureus infective endocarditis.


Assuntos
Endocardite Bacteriana/etiologia , Infecções Estafilocócicas/etiologia , Animais , Antibacterianos/administração & dosagem , Antibacterianos/farmacologia , Valva Aórtica/microbiologia , Valva Aórtica/patologia , Contagem de Colônia Microbiana , Modelos Animais de Doenças , Endocardite Bacteriana/tratamento farmacológico , Endocardite Bacteriana/metabolismo , Endocardite Bacteriana/microbiologia , Feminino , Resistência a Meticilina , Camundongos , Infecções Estafilocócicas/tratamento farmacológico , Infecções Estafilocócicas/metabolismo , Infecções Estafilocócicas/microbiologia , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/isolamento & purificação , Vancomicina/administração & dosagem , Vancomicina/farmacologia
3.
Anal Chem ; 76(6): 1761-7, 2004 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-15018580

RESUMO

Compound extraction from biological tissue often presents a challenge for the bioanalytical chemist. Labor-intensive homogenization or sonication of whole or powdered tissue is performed before compounds can be extracted and analyzed. Enzymatic digestion is commonly used for tissue dissociation and cell harvesting and offers the advantages of unattended sample preparation, potential automation, and low cost. The feasibility of enzymatic digestion as an alternate tissue preparation technique was evaluated for bioanalysis of drugs in conjunction with LC/MS/MS. Two different enzymes (collagenase and proteinase K) that are known to degrade connective tissues to allow tissue dissolution were chosen for evaluation, employing well-known antidepressants desipramine and fluoxetine as test compounds in dog and rat brain tissue. Comparison between enzymatic digestion and conventional homogenization tissue preparation was performed, including investigation of matrix ionization suppression of both methods using a postcolumn infusion system. Results showed that enzymatic digestion has extraction efficiency comparable to homogenization. Matrix ionization suppression was not observed for either the test compounds evaluated or the sample extraction method. Test compound levels of incurred tissue samples prepared by enzymatic digestion were in good agreement with the values obtained by the conventional homogenization tissue preparation, indicating that enzymatic digestion is an appropriate tissue sample preparation method.


Assuntos
Encéfalo/enzimologia , Encéfalo/metabolismo , Desipramina/análise , Fluoxetina/análise , Haloperidol/análise , Animais , Antidepressivos/análise , Cromatografia Líquida/métodos , Colagenases/metabolismo , Desipramina/administração & dosagem , Desipramina/metabolismo , Cães , Relação Dose-Resposta a Droga , Endopeptidase K/metabolismo , Esterases/metabolismo , Estudos de Viabilidade , Feminino , Fluoxetina/administração & dosagem , Fluoxetina/metabolismo , Haloperidol/administração & dosagem , Haloperidol/metabolismo , Técnicas In Vitro , Espectrometria de Massas/métodos , Ratos , Ratos Sprague-Dawley , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...